Loading…

Improving the production of BaEV lentivirus by comprehensive optimization

With the rapid development of the cell and gene therapy industry, there is an increasing demand for lentiviral vectors that can efficiently infect cells of different purposes. BaEV lentiviruses have been shown to efficiently infect hematopoietic stem cells, primary B cells, and NK cells, which tradi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of virological methods 2025-04, Vol.333, p.115106, Article 115106
Main Authors: Li, Jinxue, Xu, Wenqiang, Luo, Shengtao, Zhang, Hairong, Qiu, Xueliang, Zhang, Hao, Liu, Zhichao, Pang, Qingxiao
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c1606-3b395ae4b32993169a555499f8b99b94ff69b88aa4f03bed18bf1e935c02c6a03
container_end_page
container_issue
container_start_page 115106
container_title Journal of virological methods
container_volume 333
creator Li, Jinxue
Xu, Wenqiang
Luo, Shengtao
Zhang, Hairong
Qiu, Xueliang
Zhang, Hao
Liu, Zhichao
Pang, Qingxiao
description With the rapid development of the cell and gene therapy industry, there is an increasing demand for lentiviral vectors that can efficiently infect cells of different purposes. BaEV lentiviruses have been shown to efficiently infect hematopoietic stem cells, primary B cells, and NK cells, which traditional VSV-G lentiviruses cannot infect. However, there is a problem of low virus yield in the production of BaEV lentivirus. The formation of syncytium and apoptosis occur after plasmid transfection, and resulting in a reduction in virus production. In this study, the issue of low production of BaEV lentivirus was comprehensively improved. By increasing the cell density of inoculation, reducing the amount of BaEV plasmid, and adjusting the harvest time, the maximum titer of BaEV lentivirus reached 4.43E+ 06 IU/ml, representing an increase of 369 times compared to the unoptimized condition. Further, the purification method of lentivirus solution was optimized, and the infection titer of lentivirus reached 1.00E+ 08 IU/ml, which is 10300 times higher than pre-optimization levels. •BaEV lentivirus packing titers raised to 4.43E+ 06 IU/ml, which increased 369 times compared to the unoptimized condition.•BaEV purification titers reached 1.00E+ 08 IU/ml, which is 10300 times higher than pre-optimization levels.•The formation of syncytium and the lysis of packing cells were effectively alleviated.
doi_str_mv 10.1016/j.jviromet.2024.115106
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3150345514</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166093424002313</els_id><sourcerecordid>3150345514</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1606-3b395ae4b32993169a555499f8b99b94ff69b88aa4f03bed18bf1e935c02c6a03</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EoqXwC1WWbFrs-NF4x0MFKlViA2wt25lQR0lc4qRS-XpcpWXLamZxru_4IDQleE4wEXflvNy51tfQzVOcsjkhnGBxhsYkW8gZlhk7R-MIirhTNkJXIZQYY76g9BKNqFxQwYgYo9Wq3rZ-55qvpNtAEve8t53zTeKL5FEvP5MKms7Frj4kZp9YH3nYQBPcDhK_7VztfvQhcI0uCl0FuDnOCfp4Xr4_vc7Wby-rp4f1zBKBxYwaKrkGZmgqJSVCas45k7LIjJRGsqIQ0mSZ1qzA1EBOMlMQkJRbnFqhMZ2g2-HdeOt3D6FTtQsWqko34PugKOGYMs4Ji6gYUNv6EFoo1LZ1tW73imB10KhKddKoDhrVoDEGp8eO3tSQ_8VO3iJwPwAQf7pz0KpgHTQWcteC7VTu3X8dv3bZh44</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3150345514</pqid></control><display><type>article</type><title>Improving the production of BaEV lentivirus by comprehensive optimization</title><source>ScienceDirect Freedom Collection</source><creator>Li, Jinxue ; Xu, Wenqiang ; Luo, Shengtao ; Zhang, Hairong ; Qiu, Xueliang ; Zhang, Hao ; Liu, Zhichao ; Pang, Qingxiao</creator><creatorcontrib>Li, Jinxue ; Xu, Wenqiang ; Luo, Shengtao ; Zhang, Hairong ; Qiu, Xueliang ; Zhang, Hao ; Liu, Zhichao ; Pang, Qingxiao</creatorcontrib><description>With the rapid development of the cell and gene therapy industry, there is an increasing demand for lentiviral vectors that can efficiently infect cells of different purposes. BaEV lentiviruses have been shown to efficiently infect hematopoietic stem cells, primary B cells, and NK cells, which traditional VSV-G lentiviruses cannot infect. However, there is a problem of low virus yield in the production of BaEV lentivirus. The formation of syncytium and apoptosis occur after plasmid transfection, and resulting in a reduction in virus production. In this study, the issue of low production of BaEV lentivirus was comprehensively improved. By increasing the cell density of inoculation, reducing the amount of BaEV plasmid, and adjusting the harvest time, the maximum titer of BaEV lentivirus reached 4.43E+ 06 IU/ml, representing an increase of 369 times compared to the unoptimized condition. Further, the purification method of lentivirus solution was optimized, and the infection titer of lentivirus reached 1.00E+ 08 IU/ml, which is 10300 times higher than pre-optimization levels. •BaEV lentivirus packing titers raised to 4.43E+ 06 IU/ml, which increased 369 times compared to the unoptimized condition.•BaEV purification titers reached 1.00E+ 08 IU/ml, which is 10300 times higher than pre-optimization levels.•The formation of syncytium and the lysis of packing cells were effectively alleviated.</description><identifier>ISSN: 0166-0934</identifier><identifier>ISSN: 1879-0984</identifier><identifier>EISSN: 1879-0984</identifier><identifier>DOI: 10.1016/j.jviromet.2024.115106</identifier><identifier>PMID: 39736416</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>BaEV-LV ; CAR-NK ; Titer ; Transfection ; Ultracentrifugation</subject><ispartof>Journal of virological methods, 2025-04, Vol.333, p.115106, Article 115106</ispartof><rights>2025 Elsevier B.V.</rights><rights>Copyright © 2025 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1606-3b395ae4b32993169a555499f8b99b94ff69b88aa4f03bed18bf1e935c02c6a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39736416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Jinxue</creatorcontrib><creatorcontrib>Xu, Wenqiang</creatorcontrib><creatorcontrib>Luo, Shengtao</creatorcontrib><creatorcontrib>Zhang, Hairong</creatorcontrib><creatorcontrib>Qiu, Xueliang</creatorcontrib><creatorcontrib>Zhang, Hao</creatorcontrib><creatorcontrib>Liu, Zhichao</creatorcontrib><creatorcontrib>Pang, Qingxiao</creatorcontrib><title>Improving the production of BaEV lentivirus by comprehensive optimization</title><title>Journal of virological methods</title><addtitle>J Virol Methods</addtitle><description>With the rapid development of the cell and gene therapy industry, there is an increasing demand for lentiviral vectors that can efficiently infect cells of different purposes. BaEV lentiviruses have been shown to efficiently infect hematopoietic stem cells, primary B cells, and NK cells, which traditional VSV-G lentiviruses cannot infect. However, there is a problem of low virus yield in the production of BaEV lentivirus. The formation of syncytium and apoptosis occur after plasmid transfection, and resulting in a reduction in virus production. In this study, the issue of low production of BaEV lentivirus was comprehensively improved. By increasing the cell density of inoculation, reducing the amount of BaEV plasmid, and adjusting the harvest time, the maximum titer of BaEV lentivirus reached 4.43E+ 06 IU/ml, representing an increase of 369 times compared to the unoptimized condition. Further, the purification method of lentivirus solution was optimized, and the infection titer of lentivirus reached 1.00E+ 08 IU/ml, which is 10300 times higher than pre-optimization levels. •BaEV lentivirus packing titers raised to 4.43E+ 06 IU/ml, which increased 369 times compared to the unoptimized condition.•BaEV purification titers reached 1.00E+ 08 IU/ml, which is 10300 times higher than pre-optimization levels.•The formation of syncytium and the lysis of packing cells were effectively alleviated.</description><subject>BaEV-LV</subject><subject>CAR-NK</subject><subject>Titer</subject><subject>Transfection</subject><subject>Ultracentrifugation</subject><issn>0166-0934</issn><issn>1879-0984</issn><issn>1879-0984</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNqFkMtOwzAQRS0EoqXwC1WWbFrs-NF4x0MFKlViA2wt25lQR0lc4qRS-XpcpWXLamZxru_4IDQleE4wEXflvNy51tfQzVOcsjkhnGBxhsYkW8gZlhk7R-MIirhTNkJXIZQYY76g9BKNqFxQwYgYo9Wq3rZ-55qvpNtAEve8t53zTeKL5FEvP5MKms7Frj4kZp9YH3nYQBPcDhK_7VztfvQhcI0uCl0FuDnOCfp4Xr4_vc7Wby-rp4f1zBKBxYwaKrkGZmgqJSVCas45k7LIjJRGsqIQ0mSZ1qzA1EBOMlMQkJRbnFqhMZ2g2-HdeOt3D6FTtQsWqko34PugKOGYMs4Ji6gYUNv6EFoo1LZ1tW73imB10KhKddKoDhrVoDEGp8eO3tSQ_8VO3iJwPwAQf7pz0KpgHTQWcteC7VTu3X8dv3bZh44</recordid><startdate>202504</startdate><enddate>202504</enddate><creator>Li, Jinxue</creator><creator>Xu, Wenqiang</creator><creator>Luo, Shengtao</creator><creator>Zhang, Hairong</creator><creator>Qiu, Xueliang</creator><creator>Zhang, Hao</creator><creator>Liu, Zhichao</creator><creator>Pang, Qingxiao</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202504</creationdate><title>Improving the production of BaEV lentivirus by comprehensive optimization</title><author>Li, Jinxue ; Xu, Wenqiang ; Luo, Shengtao ; Zhang, Hairong ; Qiu, Xueliang ; Zhang, Hao ; Liu, Zhichao ; Pang, Qingxiao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1606-3b395ae4b32993169a555499f8b99b94ff69b88aa4f03bed18bf1e935c02c6a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>BaEV-LV</topic><topic>CAR-NK</topic><topic>Titer</topic><topic>Transfection</topic><topic>Ultracentrifugation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Jinxue</creatorcontrib><creatorcontrib>Xu, Wenqiang</creatorcontrib><creatorcontrib>Luo, Shengtao</creatorcontrib><creatorcontrib>Zhang, Hairong</creatorcontrib><creatorcontrib>Qiu, Xueliang</creatorcontrib><creatorcontrib>Zhang, Hao</creatorcontrib><creatorcontrib>Liu, Zhichao</creatorcontrib><creatorcontrib>Pang, Qingxiao</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of virological methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Jinxue</au><au>Xu, Wenqiang</au><au>Luo, Shengtao</au><au>Zhang, Hairong</au><au>Qiu, Xueliang</au><au>Zhang, Hao</au><au>Liu, Zhichao</au><au>Pang, Qingxiao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improving the production of BaEV lentivirus by comprehensive optimization</atitle><jtitle>Journal of virological methods</jtitle><addtitle>J Virol Methods</addtitle><date>2025-04</date><risdate>2025</risdate><volume>333</volume><spage>115106</spage><pages>115106-</pages><artnum>115106</artnum><issn>0166-0934</issn><issn>1879-0984</issn><eissn>1879-0984</eissn><abstract>With the rapid development of the cell and gene therapy industry, there is an increasing demand for lentiviral vectors that can efficiently infect cells of different purposes. BaEV lentiviruses have been shown to efficiently infect hematopoietic stem cells, primary B cells, and NK cells, which traditional VSV-G lentiviruses cannot infect. However, there is a problem of low virus yield in the production of BaEV lentivirus. The formation of syncytium and apoptosis occur after plasmid transfection, and resulting in a reduction in virus production. In this study, the issue of low production of BaEV lentivirus was comprehensively improved. By increasing the cell density of inoculation, reducing the amount of BaEV plasmid, and adjusting the harvest time, the maximum titer of BaEV lentivirus reached 4.43E+ 06 IU/ml, representing an increase of 369 times compared to the unoptimized condition. Further, the purification method of lentivirus solution was optimized, and the infection titer of lentivirus reached 1.00E+ 08 IU/ml, which is 10300 times higher than pre-optimization levels. •BaEV lentivirus packing titers raised to 4.43E+ 06 IU/ml, which increased 369 times compared to the unoptimized condition.•BaEV purification titers reached 1.00E+ 08 IU/ml, which is 10300 times higher than pre-optimization levels.•The formation of syncytium and the lysis of packing cells were effectively alleviated.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>39736416</pmid><doi>10.1016/j.jviromet.2024.115106</doi></addata></record>
fulltext fulltext
identifier ISSN: 0166-0934
ispartof Journal of virological methods, 2025-04, Vol.333, p.115106, Article 115106
issn 0166-0934
1879-0984
1879-0984
language eng
recordid cdi_proquest_miscellaneous_3150345514
source ScienceDirect Freedom Collection
subjects BaEV-LV
CAR-NK
Titer
Transfection
Ultracentrifugation
title Improving the production of BaEV lentivirus by comprehensive optimization
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T10%3A35%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improving%20the%20production%20of%20BaEV%20lentivirus%20by%20comprehensive%20optimization&rft.jtitle=Journal%20of%20virological%20methods&rft.au=Li,%20Jinxue&rft.date=2025-04&rft.volume=333&rft.spage=115106&rft.pages=115106-&rft.artnum=115106&rft.issn=0166-0934&rft.eissn=1879-0984&rft_id=info:doi/10.1016/j.jviromet.2024.115106&rft_dat=%3Cproquest_cross%3E3150345514%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1606-3b395ae4b32993169a555499f8b99b94ff69b88aa4f03bed18bf1e935c02c6a03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3150345514&rft_id=info:pmid/39736416&rfr_iscdi=true